• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用主分层权重进行以患者为中心的风险比估计:在NORCCAP结直肠癌筛查随机试验中的应用。

Patient Centered Hazard Ratio Estimation Using Principal Stratification Weights: Application to the NORCCAP Randomized Trial of Colorectal Cancer Screening.

作者信息

MacKenzie Todd A, Løberg Magnus, O'Malley A James

机构信息

Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, U.S.A.

University of Oslo, Oslo, Norway.

出版信息

Obs Stud. 2016 Mar;2:29-50. Epub 2016 Apr 24.

PMID:29644344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5891167/
Abstract

In randomized trials, the most commonly reported method of effect estimation is intention-to-treat (ITT), and to a lesser extent the per-protocol. The ITT is preferred because it is an unbiased estimator of the effect of treatment assignment. However, if there is any non-adherence the ITT is a biased estimate of the treatment effect, defined as the contrast between the potential outcome if treated versus the potential outcome if not treated. The treatment effect is most relevant to patients. Principal stratification is a framework for estimating treatment effects that combines potential outcomes and latent adherence strata. It yields an unbiased estimator of the complier average causal effect (CACE) for a difference in means or proportions, in the setting of all-or-nothing adherence. This paper addresses estimation of the causal hazard ratio for the compliers in a setting of right censoring of a time-to-event. We propose a novel approach to operationalizing principal stratification using weights. We report the results of simulations that vary the amount of adherence and selection bias that show the hazard ratio estimators we propose have minimal bias compared to the ITT, and per-protocol estimators. We demonstrate the approach using a population based randomized controlled trial of colorectal cancer screening subject to a high frequency of nonadherence in the screening arm.

摘要

在随机试验中,最常报告的效应估计方法是意向性分析(ITT),其次是符合方案分析。ITT 更受青睐,因为它是治疗分配效应的无偏估计量。然而,如果存在任何不依从情况,ITT 就是治疗效应的有偏估计,治疗效应定义为接受治疗时的潜在结果与未接受治疗时的潜在结果之间的对比。治疗效应与患者最为相关。主分层是一种估计治疗效应的框架,它将潜在结果和潜在依从分层结合起来。在全有或全无依从的情况下,它能得出均值或比例差异的依从者平均因果效应(CACE)的无偏估计量。本文探讨在事件发生时间存在右删失的情况下,依从者的因果风险比估计问题。我们提出一种使用权重来实施主分层的新方法。我们报告了模拟结果,这些模拟改变了依从程度和选择偏倚的量,结果表明与 ITT 和符合方案估计量相比,我们提出的风险比估计量偏差最小。我们使用一项基于人群的结直肠癌筛查随机对照试验来演示该方法,该试验中筛查组的不依从频率较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/5891167/138a0079563a/nihms897706f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/5891167/bc87b49a0d11/nihms897706f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/5891167/138a0079563a/nihms897706f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/5891167/bc87b49a0d11/nihms897706f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ab/5891167/138a0079563a/nihms897706f2.jpg

相似文献

1
Patient Centered Hazard Ratio Estimation Using Principal Stratification Weights: Application to the NORCCAP Randomized Trial of Colorectal Cancer Screening.使用主分层权重进行以患者为中心的风险比估计:在NORCCAP结直肠癌筛查随机试验中的应用。
Obs Stud. 2016 Mar;2:29-50. Epub 2016 Apr 24.
2
Simple Estimation of Patient-Oriented Effects From Randomized Trials: An Open and Shut CACE.从随机试验中对以患者为导向的效应进行简单估计:一目了然的CACE。
Am J Epidemiol. 2015 Sep 15;182(6):557-66. doi: 10.1093/aje/kwv065. Epub 2015 Aug 16.
3
Beyond intention to treat: what is the right question?超越意向性分析:正确的问题是什么?
Clin Trials. 2014 Feb;11(1):28-37. doi: 10.1177/1740774513504151. Epub 2013 Oct 3.
4
Estimation of treatment efficacy with complier average causal effects (CACE) in a randomized stepped wedge trial.在一项随机阶梯式楔形试验中,使用符合平均因果效应(CACE)估计治疗效果。
Am J Epidemiol. 2014 May 1;179(9):1134-42. doi: 10.1093/aje/kwu015. Epub 2014 Apr 4.
5
Intention to treat, per protocol, as treated and instrumental variable estimators given non-compliance and effect heterogeneity.在存在不依从和效应异质性的情况下,意向性分析、符合方案分析、实际治疗分析以及工具变量估计量。
Stat Med. 2009 Sep 20;28(21):2639-52. doi: 10.1002/sim.3636.
6
A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.一种用于评估具有全或无依从性的临床试验疗效的综合估计量。
Stat Med. 2017 Dec 20;36(29):4604-4615. doi: 10.1002/sim.7447. Epub 2017 Aug 18.
7
Estimating causal effects of internet interventions in the context of nonadherence.在不依从情况下估计互联网干预措施的因果效应。
Internet Interv. 2020 Aug 29;21:100346. doi: 10.1016/j.invent.2020.100346. eCollection 2020 Sep.
8
Time dependent hazard ratio estimation using instrumental variables without conditioning on an omitted covariate.基于工具变量的时变风险比估计,无需在一个遗漏协变量上进行条件推断。
BMC Med Res Methodol. 2021 Mar 20;21(1):56. doi: 10.1186/s12874-021-01245-6.
9
Clarifying selection bias in cluster randomized trials.阐明整群随机试验中的选择偏倚。
Clin Trials. 2022 Feb;19(1):33-41. doi: 10.1177/17407745211056875. Epub 2021 Dec 11.
10
A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.一种用于在具有全有或全无依从性的随机试验中实际接受治疗效果的因果比例风险估计器。
Biometrics. 2003 Mar;59(1):100-5. doi: 10.1111/1541-0420.00012.

引用本文的文献

1
Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates.用于预防中风的房颤筛查:一项针对不同参与率的工具变量荟萃分析。
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf030.
2
Discussion on "Instrumental variable estimation of the causal hazard ratio" by Linbo Wang, Eric Tchetgen Tchetgen, Torben Martinussen, and Stijn Vansteelandt.关于王琳博、埃里克·切特根·切特根、托本·马丁努森和斯蒂恩·范斯特兰特所著的《因果风险比的工具变量估计》的讨论
Biometrics. 2023 Jun;79(2):559-563. doi: 10.1111/biom.13794. Epub 2022 Nov 25.
3
Causal Proportional Hazards Estimation with a Binary Instrumental Variable.使用二元工具变量的因果比例风险估计
Stat Sin. 2021 Apr;31(2):673-699. doi: 10.5705/ss.202019.0096.
4
A causal proportional hazards estimator under homogeneous or heterogeneous selection in an IV setting.在工具变量设置中,同质或异质选择下的因果比例风险估计器。
Lifetime Data Anal. 2019 Oct;25(4):639-659. doi: 10.1007/s10985-019-09476-y. Epub 2019 May 7.

本文引用的文献

1
Does Cox analysis of a randomized survival study yield a causal treatment effect?随机生存研究的Cox分析能否得出因果治疗效果?
Lifetime Data Anal. 2015 Oct;21(4):579-93. doi: 10.1007/s10985-015-9335-y. Epub 2015 Jun 24.
2
Randomized trial of four financial-incentive programs for smoking cessation.四项戒烟经济激励方案的随机试验。
N Engl J Med. 2015 May 28;372(22):2108-17. doi: 10.1056/NEJMoa1414293. Epub 2015 May 13.
3
Bias in estimating the causal hazard ratio when using two-stage instrumental variable methods.使用两阶段工具变量法时因果风险比估计中的偏差。
Stat Med. 2015 Jun 30;34(14):2235-65. doi: 10.1002/sim.6470. Epub 2015 Mar 20.
4
Instrumental variable estimation in a survival context.生存背景下的工具变量估计
Epidemiology. 2015 May;26(3):402-10. doi: 10.1097/EDE.0000000000000262.
5
Using instrumental variables to estimate a Cox's proportional hazards regression subject to additive confounding.使用工具变量估计受相加性混杂因素影响的Cox比例风险回归。
Health Serv Outcomes Res Methodol. 2014 Jun;14(1-2):54-68. doi: 10.1007/s10742-014-0117-x.
6
Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised controlled trial.机械与手动胸外按压在院外心脏骤停中的应用(PARAMEDIC):一项实用的、整群随机对照试验。
Lancet. 2015 Mar 14;385(9972):947-55. doi: 10.1016/S0140-6736(14)61886-9. Epub 2014 Nov 16.
7
Instrumental variable additive hazards models.工具变量相加风险模型
Biometrics. 2015 Mar;71(1):122-130. doi: 10.1111/biom.12244. Epub 2014 Oct 8.
8
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.结肠镜筛查对结直肠癌发病率和死亡率的影响:一项随机临床试验。
JAMA. 2014 Aug 13;312(6):606-15. doi: 10.1001/jama.2014.8266.
9
Principal stratification: a broader vision.主分层:更广阔的视野。
Int J Biostat. 2013 Oct 11;9(2):307-13. doi: 10.1515/ijb-2013-0045.
10
Randomized trials analyzed as observational studies.作为观察性研究进行分析的随机试验。
Ann Intern Med. 2013 Oct 15;159(8):560-2. doi: 10.7326/0003-4819-159-8-201310150-00709.